TNON has 36-month beta value of 1.30. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TNON is 6.20M, and currently, short sellers hold a 9.72% ratio of that float. The average trading volume of TNON on April 10, 2025 was 7.11M shares.
TNON) stock’s latest price update
Tenon Medical Inc (NASDAQ: TNON)’s stock price has dropped by -4.40 in relation to previous closing price of 1.15. Nevertheless, the company has seen a loss of -17.34% in its stock price over the last five trading days. accessnewswire.com reported 2025-03-25 that LOS GATOS, CA / ACCESS Newswire / March 25, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) (“Tenon” or the “Company”), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has entered into a securities purchase agreement with a single healthcare focused institutional investor for the issuance and sale of 1,271,500 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules at a purchase price of $2.00. In a concurrent private placement (the “Private Placement” and together with the registered offering, the “Offerings”), the Company also agreed to issue to the same investor warrants to purchase up to 1,271,500 shares of its common stock (the “Common Warrants”).
TNON’s Market Performance
Tenon Medical Inc (TNON) has experienced a -17.34% fall in stock performance for the past week, with a -0.95% drop in the past month, and a -40.57% drop in the past quarter. The volatility ratio for the week is 17.26%, and the volatility levels for the past 30 days are at 21.14% for TNON. The simple moving average for the last 20 days is -29.65% for TNON’s stock, with a simple moving average of -64.64% for the last 200 days.
TNON Trading at -25.13% from the 50-Day Moving Average
After a stumble in the market that brought TNON to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.04% of loss for the given period.
Volatility was left at 21.14%, however, over the last 30 days, the volatility rate increased by 17.26%, as shares surge +6.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.69% lower at present.
During the last 5 trading sessions, TNON fell by -16.54%, which changed the moving average for the period of 200-days by -75.25% in comparison to the 20-day moving average, which settled at $1.5632. In addition, Tenon Medical Inc saw -41.52% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for TNON
Current profitability levels for the company are sitting at:
- -4.2 for the present operating margin
- 0.47 for the gross margin
The net margin for Tenon Medical Inc stands at -4.17. The total capital return value is set at -1.73. Equity return is now at value -405.19, with -168.93 for asset returns.
Based on Tenon Medical Inc (TNON), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -23.08. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -404.88.
Currently, EBITDA for the company is -12.98 million with net debt to EBITDA at 0.47. When we switch over and look at the enterprise to sales, we see a ratio of 0.19. The receivables turnover for the company is 3.8for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.39.
Conclusion
To put it simply, Tenon Medical Inc (TNON) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
